Gone to pot–a review of the association between cannabis and psychosis R Radhakrishnan, ST Wilkinson, DC D’Souza Frontiers in psychiatry 5, 54, 2014 | 466 | 2014 |
Suicide: an Indian perspective R Radhakrishnan, C Andrade Indian journal of psychiatry 54 (4), 304-319, 2012 | 363 | 2012 |
Marijuana Legalization: Impact on Physicians and Public Health ST Wilkinson, S Yarnell, R Radhakrishnan, SA Ball, DC D'Souza Annual Review of Medicine, 2015 | 253 | 2015 |
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis G Hindley, K Beck, F Borgan, CE Ginestet, R McCutcheon, D Kleinloog, ... The Lancet Psychiatry 7 (4), 344-353, 2020 | 202 | 2020 |
Hormonal treatments for major depressive disorder: state of the art JB Dwyer, A Aftab, R Radhakrishnan, A Widge, CI Rodriguez, ... American Journal of Psychiatry 177 (8), 686-705, 2020 | 174 | 2020 |
The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments C Andrade, R Radhakrishnan Indian journal of psychiatry 51 (1), 12-25, 2009 | 173 | 2009 |
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled … DC D'Souza, J Cortes-Briones, G Creatura, G Bluez, H Thurnauer, ... The Lancet Psychiatry, 2018 | 158 | 2018 |
Human Laboratory Studies on Cannabinoids and Psychosis M Sherif, R Radhakrishnan, DC D'Souza, M Ranganathan Biological Psychiatry, 2016 | 153 | 2016 |
Impact of cannabis use on the development of psychotic disorders ST Wilkinson, R Radhakrishnan, DC D’Souza Current addiction reports 1, 115-128, 2014 | 147 | 2014 |
Prayer and healing: A medical and scientific perspective on randomized controlled trials C Andrade, R Radhakrishnan Indian journal of psychiatry 51 (4), 247-253, 2009 | 134 | 2009 |
Grey matter volume differences associated with extremely low levels of cannabis use in adolescence C Orr, P Spechler, Z Cao, M Albaugh, B Chaarani, S Mackey, D D'Souza, ... Journal of Neuroscience 39 (10), 1817-1827, 2019 | 113 | 2019 |
Reduced brain cannabinoid receptor availability in schizophrenia M Ranganathan, J Cortes-Briones, R Radhakrishnan, H Thurnauer, ... Biological psychiatry 79 (12), 997-1005, 2016 | 113 | 2016 |
Association of cannabis use during adolescence with neurodevelopment MD Albaugh, J Ottino-Gonzalez, A Sidwell, C Lepage, A Juliano, ... JAMA psychiatry 78 (9), 1031-1040, 2021 | 108 | 2021 |
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications ST Wilkinson, R Radhakrishnan, DC D'Souza Journal of Clinical Psychiatry 77 (8), 1050-1064, 2016 | 105 | 2016 |
Thyroid dysfunction in major psychiatric disorders in a hospital-based sample. R Radhakrishnan, S Calvin, J Singh, B Thomas, K Srinivasan Indian Journal of Medical Research 138, 888-893, 2013 | 94 | 2013 |
The Link Between the Immune System, Environment, and Psychosis R Radhakrishnan, M Kaser, S Guloksuz Schizophrenia Bulletin, 2017 | 89 | 2017 |
Acute effects of THC on time perception in frequent and infrequent cannabis users RA Sewell, A Schnakenberg, J Elander, R Radhakrishnan, A Williams, ... Psychopharmacology 226, 401-413, 2013 | 89 | 2013 |
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study DC D'souza, R Radhakrishnan, E Perry, S Bhakta, NM Singh, R Yadav, ... Neuropsychopharmacology 38 (3), 492-503, 2013 | 86 | 2013 |
Evidence that environmental and familial risks for psychosis additively impact a multidimensional subthreshold psychosis syndrome LK Pries, S Guloksuz, M Ten Have, R De Graaf, S Van Dorsselaer, ... Schizophrenia Bulletin 44 (4), 710-719, 2018 | 74 | 2018 |
Asian Indians in America: The influence of values and culture on mental health. RM Chandra, L Arora, UM Mehta, A Asnaani, R Radhakrishnan Asian J Psychiatry, S1876-2018(15)00222-1., 2015 | 72 | 2015 |